These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9705383)

  • 1. The gamma interferon gene knockout mouse: a highly sensitive model for evaluation of therapeutic agents against Cryptosporidium parvum.
    Griffiths JK; Theodos C; Paris M; Tzipori S
    J Clin Microbiol; 1998 Sep; 36(9):2503-8. PubMed ID: 9705383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection.
    Lacroix S; Mancassola R; Naciri M; Laurent F
    Infect Immun; 2001 Mar; 69(3):1635-42. PubMed ID: 11179338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium parvum-infected gamma-interferon knockout mice.
    Smith LM; Bonafonte MT; Mead JR
    J Parasitol; 2000 Apr; 86(2):300-7. PubMed ID: 10780549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection.
    Theodos CM; Sullivan KL; Griffiths JK; Tzipori S
    Infect Immun; 1997 Nov; 65(11):4761-9. PubMed ID: 9353062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-gamma monoclonal antibody for drug testing against Cryptosporidium parvum.
    Tzipori S; Rand W; Theodos C
    J Infect Dis; 1995 Oct; 172(4):1160-4. PubMed ID: 7561204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
    Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
    Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of experimental Cryptosporidium parvum infection in IFN-gamma knockout mice.
    You X; Mead JR
    Parasitology; 1998 Dec; 117 ( Pt 6)():525-31. PubMed ID: 9881376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model.
    Baishanbo A; Gargala G; Duclos C; François A; Rossignol JF; Ballet JJ; Favennec L
    J Antimicrob Chemother; 2006 Feb; 57(2):353-5. PubMed ID: 16361328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice.
    Smith LM; Bonafonte MT; Campbell LD; Mead JR
    Exp Parasitol; 2001 Jul; 98(3):123-33. PubMed ID: 11527435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of curcumin and paromomycin against Cryptosporidium parvum infection in a BALB/c model.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Vet Parasitol; 2018 Jan; 250():7-14. PubMed ID: 29329627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum.
    Healey MC; Yang S; Rasmussen KR; Jackson MK; Du C
    J Parasitol; 1995 Feb; 81(1):114-6. PubMed ID: 7876965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin.
    Tzipori S; Rand W; Griffiths J; Widmer G; Crabb J
    Clin Diagn Lab Immunol; 1994 Jul; 1(4):450-63. PubMed ID: 8556484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection.
    Lacroix-Lamandé S; Mancassola R; Naciri M; Laurent F
    Infect Immun; 2002 Apr; 70(4):2090-9. PubMed ID: 11895975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group.
    Hewitt RG; Yiannoutsos CT; Higgs ES; Carey JT; Geiseler PJ; Soave R; Rosenberg R; Vazquez GJ; Wheat LJ; Fass RJ; Antoninievic Z; Walawander AL; Flanigan TP; Bender JF
    Clin Infect Dis; 2000 Oct; 31(4):1084-92. PubMed ID: 11049793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Exp Parasitol; 2018 Dec; 195():59-65. PubMed ID: 30385266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on: effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.
    Dugue GA
    J Antimicrob Chemother; 2004 Feb; 53(2):403; author reply 403. PubMed ID: 14729752
    [No Abstract]   [Full Text] [Related]  

  • 17. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection.
    Aguirre SA; Perryman LE; Davis WC; McGuire TC
    J Immunol; 1998 Aug; 161(4):1891-900. PubMed ID: 9712058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptosporidium parvum bovine genotype oocysts in the respiratory samples of an AIDS patient: efficacy of treatment with a combination of azithromycin and paromomycin.
    Meamar AR; Rezaian M; Rezaie S; Mohraz M; Kia EB; Houpt ER; Solaymani-Mohammadi S
    Parasitol Res; 2006 May; 98(6):593-5. PubMed ID: 16416289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility differences to Cryptosporidium parvum infection in two strains of gamma interferon knockout mice.
    Mead JR; You X
    J Parasitol; 1998 Oct; 84(5):1045-8. PubMed ID: 9794653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the prophylactic and therapeutic effects of paromomycin, recombinant IL-12 alone or in combination against Cryptosporidium parvum infection in immunosuppressed mice.
    Gamra MM; el-Hosseiny LM
    J Egypt Soc Parasitol; 2003 Apr; 33(1):109-22. PubMed ID: 12739805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.